Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay

Details 詳細情報について

• CRID

  1360294643784999936

• DOI

  10.1007/s11102-021-01192-x

• ISSN

  15737403

  1386341X

• Web Site

  https://link.springer.com/content/pdf/10.1007/s11102-021-01192-x.pdf

  https://link.springer.com/article/10.1007/s11102-021-01192-x/fulltext.html

• Data Source

  • Crossref
  • KAKEN